Back to Results
First PageMeta Content
Vaccine / CD134 / Biology / Forward-looking statement / Vaccination / Business law / Agenus


Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed]
Add to Reading List

Document Date: 2014-05-30 08:46:05

Open Document

File Size: 316,77 KB

Share Result on Facebook

Company

IgG / GlaxoSmithKline / Agenus Inc. / Janssen / Google / /

/

Event

FDA Phase / /

IndustryTerm

checkpoint modulators / /

MedicalCondition

cancer / diseases / infectious disease / /

Organization

Securities and Exchange Commission / /

Person

Robert Stein / /

/

Position

Chief Scientific Officer / Vice President Investor Relations and Corporate Communications jonae.barnes@agenusbio.com / /

Product

Retrocyte Display / Stimulon® / /

URL

www.agenusbio.com / www.agenusbio.com/webcast / /

SocialTag